TY PHAR.(SZ:002728) Zheng Quan Zhi Xing·2025-07-16 16:26Core Viewpoint - The legal opinion letter from Grandall Law Firm (Shenzhen) confirms that the adjustment of the exercise price for the 2021 stock option incentive plan of Te Yi Pharmaceutical Group Co., Ltd. has obtained the necessary approvals and complies with relevant regulations [1][4][5]. Group 1: Approval and Authorization - The board of directors has authorized the adjustment of the exercise price for the stock option incentive plan, which is now set at 6.19 yuan per share [4][5]. - The adjustment is deemed to be in accordance with the provisions of the stock incentive plan and relevant regulations [4][5]. Group 2: Specifics of the Adjustment - The adjustment was necessitated by a cash dividend distribution of 0.50 yuan per 10 shares, with no stock dividends or capital increases [4][5]. - The formula used for the adjustment of the exercise price is P = P0 - V, where P0 is the original exercise price, V is the cash dividend per share, and P is the adjusted exercise price [5]. - Following the adjustment, the exercise price changed from 6.24 yuan per share to 6.19 yuan per share [5]. Group 3: Conclusion - The legal opinion concludes that the adjustment has received the necessary approvals and is in compliance with the relevant laws and regulations [5][6]. - The company is required to fulfill its information disclosure obligations and complete the necessary procedures related to this adjustment [5].